CN102106184B - 取代的哌啶子基苯基噁唑烷酮 - Google Patents

取代的哌啶子基苯基噁唑烷酮 Download PDF

Info

Publication number
CN102106184B
CN102106184B CN200780016549.8A CN200780016549A CN102106184B CN 102106184 B CN102106184 B CN 102106184B CN 200780016549 A CN200780016549 A CN 200780016549A CN 102106184 B CN102106184 B CN 102106184B
Authority
CN
China
Prior art keywords
compound
formula
compounds
pharmaceutically acceptable
converting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780016549.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN102106184A (zh
Inventor
M·V·帕特尔
M·芬萨尔卡
V·J·帕蒂尔
M·D·辛德基德卡
P·K·德斯潘德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of CN102106184A publication Critical patent/CN102106184A/zh
Application granted granted Critical
Publication of CN102106184B publication Critical patent/CN102106184B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B6/00—Heating by electric, magnetic or electromagnetic fields
    • H05B6/02—Induction heating
    • H05B6/10—Induction heating apparatus, other than furnaces, for specific applications
    • H05B6/12—Cooking devices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN200780016549.8A 2006-05-09 2007-05-08 取代的哌啶子基苯基噁唑烷酮 Expired - Fee Related CN102106184B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN719MU2006 2006-05-09
IN719/MUM/2006 2006-05-09
PCT/IB2007/001179 WO2007132314A2 (en) 2006-05-09 2007-05-08 Substituted piperidino phenyloxazolidinones

Publications (2)

Publication Number Publication Date
CN102106184A CN102106184A (zh) 2011-06-22
CN102106184B true CN102106184B (zh) 2014-04-09

Family

ID=38694273

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780016549.8A Expired - Fee Related CN102106184B (zh) 2006-05-09 2007-05-08 取代的哌啶子基苯基噁唑烷酮

Country Status (13)

Country Link
US (1) US8217058B2 (cg-RX-API-DMAC7.html)
EP (1) EP2018792B1 (cg-RX-API-DMAC7.html)
JP (1) JP5313126B2 (cg-RX-API-DMAC7.html)
KR (1) KR101345445B1 (cg-RX-API-DMAC7.html)
CN (1) CN102106184B (cg-RX-API-DMAC7.html)
AU (1) AU2007251289A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712535A2 (cg-RX-API-DMAC7.html)
CA (1) CA2651634C (cg-RX-API-DMAC7.html)
ES (1) ES2556183T3 (cg-RX-API-DMAC7.html)
MX (1) MX2008013371A (cg-RX-API-DMAC7.html)
RU (1) RU2008148319A (cg-RX-API-DMAC7.html)
WO (1) WO2007132314A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809724B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
WO2007132314A2 (en) * 2006-05-09 2007-11-22 Wockhardt Ltd Substituted piperidino phenyloxazolidinones
EP2069339B1 (en) * 2006-09-25 2011-05-18 Wockhardt Research Centre Substituted piperidinophenyl oxazolidinones
US20130296569A1 (en) * 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
US11857352B2 (en) 2016-09-06 2024-01-02 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
WO2023209678A1 (en) * 2022-04-29 2023-11-02 Zenal Pharmachem Llc Aryl azo pyrazole derivatives as antimicrobial agent
WO2023209677A2 (en) * 2022-04-29 2023-11-02 Zenal Pharmachem Llc A novel aryl azo pyrazole compound and its synthesis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1143961A (zh) * 1994-03-15 1997-02-26 法玛西雅厄普约翰公司 噁唑烷酮衍生物和含有它们的药物组合物
US20050143421A1 (en) * 2003-09-08 2005-06-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668285A (en) 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US5668286A (en) * 1994-03-15 1997-09-16 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions containing them
AU2003272071A1 (en) * 2002-07-11 2004-02-02 Wockhardt Limited Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them
US20090018123A1 (en) * 2005-06-20 2009-01-15 Milind D Sindkhedkar Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation
WO2007132314A2 (en) * 2006-05-09 2007-11-22 Wockhardt Ltd Substituted piperidino phenyloxazolidinones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1143961A (zh) * 1994-03-15 1997-02-26 法玛西雅厄普约翰公司 噁唑烷酮衍生物和含有它们的药物组合物
US20050143421A1 (en) * 2003-09-08 2005-06-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy

Also Published As

Publication number Publication date
ES2556183T3 (es) 2016-01-13
KR20090028699A (ko) 2009-03-19
CA2651634C (en) 2013-07-30
EP2018792A4 (en) 2012-12-05
KR101345445B1 (ko) 2013-12-27
CN102106184A (zh) 2011-06-22
WO2007132314A3 (en) 2011-07-14
EP2018792A2 (en) 2009-01-28
JP5313126B2 (ja) 2013-10-09
ZA200809724B (en) 2011-10-26
MX2008013371A (es) 2009-02-06
RU2008148319A (ru) 2010-06-20
US20100056581A1 (en) 2010-03-04
US8217058B2 (en) 2012-07-10
BRPI0712535A2 (pt) 2012-09-04
EP2018792B1 (en) 2015-09-16
JP2009536939A (ja) 2009-10-22
CA2651634A1 (en) 2007-11-22
AU2007251289A1 (en) 2007-11-22
WO2007132314A2 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
JP5313126B2 (ja) 置換ピペリジノフェニルオキサゾリジノン
JP3628329B2 (ja) オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
JP6013734B2 (ja) キノロン化合物の製造方法
JP2000204084A (ja) チオカルバミド酸誘導体
EP1912648B1 (en) Quinoline derivatives as antibacterial agents
EP2662371A1 (en) (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel
EP1902050B1 (en) Oxazolidinone derivatives and use thereof as antibiotics
US20040077626A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
US8507540B2 (en) Oxazolidinone derivatives containing new bicyclic group, having antibacterial activity, and method for treating pathogenic bacterial infections using the same
WO2005113520A1 (en) Substituted 2,3,5-trifluorphenyl oxazolidinones for use as antibacterial agents
US20090137553A1 (en) Thiazepine Oxazolidinones as Antibacterial Agents
EP1899331B1 (en) Homomorpholine oxazolidinones as antibacterial agents
CA2614105A1 (en) Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
US20040235900A1 (en) Antimicrobial oxazolifinones with improved pharmacokinetic profile and safety advantages
US7435751B2 (en) 7-Fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
WO2007088438A2 (en) Benzisoxazole oxazolidinones as antibacterial agents
JP2008521792A (ja) 抗菌薬としてのジアゼピンオキサゾリジノン
BR112020002348B1 (pt) Derivados de quinolina para tratamento de infecções por helmintos
BR122025018357A2 (pt) Derivados de quinolina para tratamento de infecções por helmintos
CA2670774A1 (en) Substituted piperizines for the treatment of pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140409

Termination date: 20190508

CF01 Termination of patent right due to non-payment of annual fee